Page 54 - Read Online
P. 54

Rawn et al. J Environ Expo Assess 2024;3:16  https://dx.doi.org/10.20517/jeea.2024.04  Page 3 of 17

                                        -1
               ranged from 0.56 to 7.72 ng·g  lipid, which shows that concentrations continued to increase into the early
                                                                        [36]
               2000s, prior to regulatory action being taken on these chemicals . North American studies measuring
               PBDEs (consistently including Σ28, 47, 99, 100, 153) in human milk during the early to mid-2000s found
               concentrations to be higher than observed in Europe during a similar period (range 0.1-2,010 ng·g
                                                                                                         -1
               lipid) . Since HBCD has not been as widely studied as PBDEs, temporal trends were not readily established
                    [37]
               in human milk globally [38,39] . In addition to differences in temporal patterns, concentrations of these legacy
               BFRs vary among countries and regions.


               The determination of PBDEs and HBCD in human milk is important because these data allow researchers
               to determine maternal exposure via their milk concentrations. Additionally, human milk is often the sole
               source of nutrition for infants and very young children, which means it represents an important dietary
               exposure to BFRs for this demographic. Owing to the fact that infants and very young children are growing
               and changing rapidly, BFR exposure during this phase of life may impact their development since these
               compounds are associated with impacts on endocrine function and frequently related to thyroid function
               disruption [13,40,41] . Although exposure at critical developmental stages may not result in immediate impacts,
               PBDE  exposure  can  lead  to  increased  risk  of  disease  at  later  life  stages  (e.g.,  diabetes,  cancer,
               neurobehavioural effects) [41-43] , and HBCD has also been associated with neurobehavioural impacts and
                                           [40]
                                                                                    [13]
               changes in sex-related hormones , resulting in effects on behaviour and memory .
               Despite the presence of persistent organic contaminants, including BFRs, in human milk, the World Health
               Organization (WHO) recommends that mothers feed children human milk exclusively for the first six
               months, because of the presence of important nutritional constituents and positive health effects for the
               mothers and their babies . In addition, breastfed infants are reported to have a lower incidence of obesity
                                    [44]
                        [45]
               later in life .

               The present study, known as the Maternal-Infant Research on Environmental Chemicals (MIREC) study,
               was  undertaken  across  Canada  between  2008  and  2011  to  measure  maternal  concentrations  of
               environmental chemicals during pregnancy and in the milk following the birth of their babies . The work
                                                                                               [46]
               described herein is focused on the measurement of PBDEs and HBCD in human milk.

               EXPERIMENTAL
               Study population and sampling
               Participants for the MIREC study were recruited from across Canada to allow for a pan-Canadian
               perspective on maternal environmental chemical concentrations. In addition to providing biomonitoring
               data on the participants, this work supported the determination of infant dietary exposure via human milk
               sampling. Research centres were identified as possible recruitment sites if it was determined that existing
               frameworks for clinical obstetric research were in place prior to being associated with the MIREC study. In
               advance of confirming any clinic as a MIREC recruitment site or study centre, each clinic was required to
               obtain ethics board approval from their own research centre, Health Canada’s ethics board, and the ethics
               board of the MIREC coordination centre in CHU Sainte Justine, Québec. Once a clinic was confirmed to be
               a MIREC study centre, recruitment was undertaken during prenatal clinics . Study centres were
                                                                                     [46]
               established in 10 cities (from six provinces) across southern Canada, from west to east: Vancouver (British
               Columbia); Edmonton (Alberta); Winnipeg (Manitoba); Hamilton, Kingston, Ottawa, Sudbury and
               Toronto (Ontario); Montréal (Québec) and Halifax (Nova Scotia).


               Eligibility requirements were limited to women aged 18 or above, in the first 14 weeks of gestation, and
               capable of communicating in either English or French . Among the women approached regarding the
                                                               [46]
   49   50   51   52   53   54   55   56   57   58   59